Coronary Thrombosis Case in Female Patient with COVID-19 Confirmed Case: Coincidence or Complication?
The worldwide health impact of the COVID-19 epidemic has been felt all across the world, mostly due to respiratory issues, but many additional signs such as cardiac manifestations and different thromboembolisms have also been observed. Case Summary. We provide you with a 48-year-old female patient with COVID-19 pneumonia following a severe infection, who developed Unstable Angina due to coronary thrombosis. She has a history of hypertension and obese posture. No diabetes, hypercholesterolemia, or smoking habit had been recorded. And she still has regular menstrual cycle. Around a month prior to being referred to our hospital, this patient has been admitted to ICU of satellite hospital. She was treated with ventilator and discharged around a week before she was admitted to our Emergency Department. She had typical chest pain with ST-segment depression ECG at antero-septal area. PCI was performed and a large thrombosis was found at LAD artery. Discussion: Many studies have showed that COVID-19, through various ways, has developed thromboembolism both in arteries and venous system. The actual process of thrombus development in the coronary arteries is unknown, however, it is thought that pro-inflammatory cytokinesis released by the body, which stimulates the coagulation cascade and prevent fibrinolysis, are the major cause. This condition that leads to hypercoagulable state which eventually makes an increased risk of thromboembolism.
The European Society of Cardiology. 2020. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic.
Shams A., Ata F., Mushtaq K., Munir W., Yousaf Z. 2020. Coronary Thrombosis in A Young Male with COVID-19. IDCases. 2020; 21
Iba T., Levy J.H., Connors J.M., Warkentin T.E., Thachil J., Levi M. 2020. The Unique Characteristics of COVID-19 Coagulopathy. Crit Care. 2020 Jun 18; 24 (1): 360
Levi M., Thachil J., Iba T., Levy J.. Coagulation Abnormalities and Thrombosis in Patients with COVID-19 Infection. Lancet Haematol. 2020; S2352-3026(20): 30145–9.
Ibanez B., James S., Agewall S., Antunes M.J., Bucciarelli-Ducci C.,Bueno H., et al. 2017. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC), European Heart Journal, Volume 39, Issue 2, 07 January 2018, Pages 161.
Atallah B., Mallah S.I., AlMahmeed W. 2020. Anticoagulation in COVID-19, European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 260–261.
Copyright (c) 2022 Yosua Hendriko Manurung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Cardiovascular and Cardiometabolic Journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
Authors who publish with Cardiovascular and Cardiometabolic Journal agree to the following terms:
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution ShareAlike 4.0 International License (CC BY-SA).